Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer Sees Celebrex Script Growth After Bextra Withdrawal

Apr 19 2005

• By Lee Kalowski

Related Content

Celebrex Long-Term Safety Study Planned

Apr 07 2005

Silver Lining For Pfizer? Celebrex Well-Positioned In NSAID Class

Apr 07 2005

Pfizer Celebrex Sales Reps Will Discuss Alternate Therapy, FDA Says

Dec 20 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window